Related Articles
MEK1/2 inhibition enhances the radiosensitivity of cancer cells by downregulating survival and growth signals mediated by EGFR ligands
RACK1 affects glioma cell growth and differentiation through the CNTN2-mediated RTK/Ras/MAPK pathway
GLI inhibitor GANT61 kills melanoma cells and acts in synergy with obatoclax
Pharmacological targeting of the constitutively activated MEK/MAPK-dependent signaling pathway in glioma cells inhibits cell proliferation and migration
PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules